Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed May 7, 2020 · 10-Q · 37 days after period end · 0001104659-20-057690
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$8.11M | -$5.03M | -$2.30M | -$1.79M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 7, 2020 · 37 d after period end
